320 related articles for article (PubMed ID: 11839715)
1. Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression.
Biasi F; Tessitore L; Zanetti D; Cutrin JC; Zingaro B; Chiarpotto E; Zarkovic N; Serviddio G; Poli G
Gut; 2002 Mar; 50(3):361-7. PubMed ID: 11839715
[TBL] [Abstract][Full Text] [Related]
2. 4-hydroxynonenal and transforming growth factor-beta1 expression in colon cancer.
Zanetti D; Poli G; Vizio B; Zingaro B; Chiarpotto E; Biasi F
Mol Aspects Med; 2003; 24(4-5):273-80. PubMed ID: 12893005
[TBL] [Abstract][Full Text] [Related]
3. 4-hydroxynonenal and TGF-beta1 concur in inducing antiproliferative effects on the CaCo-2 human colon adenocarcinoma cell line.
Vizio B; Poli G; Chiarpotto E; Biasi F
Biofactors; 2005; 24(1-4):237-46. PubMed ID: 16403984
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
[TBL] [Abstract][Full Text] [Related]
6. c-Jun N-terminal kinase upregulation as a key event in the proapoptotic interaction between transforming growth factor-beta1 and 4-hydroxynonenal in colon mucosa.
Biasi F; Vizio B; Mascia C; Gaia E; Zarkovic N; Chiarpotto E; Leonarduzzi G; Poli G
Free Radic Biol Med; 2006 Aug; 41(3):443-54. PubMed ID: 16843825
[TBL] [Abstract][Full Text] [Related]
7. Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.
Wang QS; Guda K; Papanikolaou A; Dong M; Rosenberg DW
Int J Oncol; 2000 Sep; 17(3):551-8. PubMed ID: 10938397
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma.
Bellone G; Carbone A; Tibaudi D; Mauri F; Ferrero I; Smirne C; Suman F; Rivetti C; Migliaretti G; Camandona M; Palestro G; Emanuelli G; Rodeck U
Eur J Cancer; 2001 Jan; 37(2):224-33. PubMed ID: 11166150
[TBL] [Abstract][Full Text] [Related]
10. Expression of transforming growth factor beta receptors in normal human colon and sporadic adenocarcinomas.
Eskinazi R; Resibois A; Svoboda M; Peny MO; Adler M; Robberecht P; Van Laethem JL
Gastroenterology; 1998 Jun; 114(6):1211-20. PubMed ID: 9609758
[TBL] [Abstract][Full Text] [Related]
11. Down-regulated expression of transforming growth factor beta 1 mRNA in endometrial carcinoma.
Perlino E; Loverro G; Maiorano E; Giannini T; Cazzolla A; Napoli A; Fiore MG; Ricco R; Marra E; Selvaggi L
Br J Cancer; 1998 Apr; 77(8):1260-6. PubMed ID: 9579831
[TBL] [Abstract][Full Text] [Related]
12. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
[TBL] [Abstract][Full Text] [Related]
13. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
Picon A; Gold LI; Wang J; Cohen A; Friedman E
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1 modulates metalloproteinase-2 and -9, nitric oxide, RhoA and alpha-smooth muscle actin expression in colon adenocarcinoma cells.
Paduch R; Kandefer-Szerszeń M; Szuster-Ciesielska A; Plewka K
Cell Biol Int; 2010 Jan; 34(2):213-23. PubMed ID: 19947919
[TBL] [Abstract][Full Text] [Related]
15. Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors.
Shao J; Sheng H; Aramandla R; Pereira MA; Lubet RA; Hawk E; Grogan L; Kirsch IR; Washington MK; Beauchamp RD; DuBois RN
Carcinogenesis; 1999 Feb; 20(2):185-91. PubMed ID: 10069452
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
17. High tumor grade in salivary gland mucoepidermoid carcinomas and loss of expression of transforming growth factor beta receptor type II.
Dillard DG; Muller S; Cohen C; Bloch D; Del Gaudio JM; Gal AA
Arch Otolaryngol Head Neck Surg; 2001 Jun; 127(6):683-6. PubMed ID: 11405868
[TBL] [Abstract][Full Text] [Related]
18. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
Fujimoto K; Sheng H; Shao J; Beauchamp RD
Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of transforming growth factor β1 in malignant prostate cells is partly caused by a runaway of TGF-β1 auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF-β type I receptor.
Yu N; Kozlowski JM; Park II; Chen L; Zhang Q; Xu D; Doll JA; Crawford SE; Brendler CB; Lee C
Urology; 2010 Dec; 76(6):1519.e8-13. PubMed ID: 21030067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
